Evidence map›Paper›PMID 39055582›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2024

May Measurement Month 2021: an analysis of blood pressure screening results from Paraguay.

Maria Paniagua, José Ortellado, Thomas Beaney, Jonathan Clarke, Manuel Castillo, Abdón Villamayor, Neil R Poulter, Rocío Aparicio

Abstract read
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. May Measurement Month 2022: an analysis of blood pressure screening results from Paraguay.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria PaniaguaNational Program for Cardiovascular Prevention, Ministry of Public Health and Social Welfare, Pettirossi & Brasil, Asuncion, PC 1548, Paraguay.
José OrtelladoNational Program for Cardiovascular Prevention, Ministry of Public Health and Social Welfare, Pettirossi & Brasil, Asuncion, PC 1548, Paraguay.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Jonathan ClarkeImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Manuel CastilloNational Program for Cardiovascular Prevention, Ministry of Public Health and Social Welfare, Pettirossi & Brasil, Asuncion, PC 1548, Paraguay.
Abdón VillamayorNational Program for Cardiovascular Prevention, Ministry of Public Health and Social Welfare, Pettirossi & Brasil, Asuncion, PC 1548, Paraguay.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.ORCID https://orcid.org/0000-0002-6292-997X
Rocío AparicioNational Program for Cardiovascular Prevention, Ministry of Public Health and Social Welfare, Pettirossi & Brasil, Asuncion, PC 1548, Paraguay.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to highlight the importance of measuring blood pressure (BP) to identify new, known, and treated individuals with hypertension and to raise awareness in the general population about the importance of good BP control. In Paraguay, 3663 individuals aged ≥18 years of both sexes were recruited from May to November 2021 as part of the May Measurement Month (MMM) campaign, which was initiated by the International Society of Hypertension in 2017. Volunteers of 18 regional health teams applied the questionnaire provided by the MMM 2021 organization throughout the country. Due to COVID-19 constraints, the majority of the questionnaires (52.2%) were administered in health centres of the Ministry of Health and concluded with three BP and pulse readings using OMRON-automated BP measurement devices. Hypertension was defined as a systolic BP ≥ 140 mmHg or as a diastolic BP ≥ 90 mmHg or taking antihypertensive medication. We found that 57.4% of screenees were hypertensive and 72.9% of these (82.3% of women and 59.4% of men) had known hypertension. Of patients with hypertension, 70.1% were on antihypertensive medication, and 40.9% had controlled BP (<140/90 mmHg). Among hypertensives detected, 79.7% of women were on antihypertensive medication and 44.1% had controlled BP, while 56.4% of men were on treatment and 34.3% had controlled BP. In summary, we found high levels of hypertension with high rates of awareness and treatment particularly among women, although control rates were low particularly among men. This may be because most screening was conducted predominately in hospital settings.

Indexed as

Blood pressureControlled blood pressureDetectionHypertensionTreatment

Identifiers

PMID39055582
PMCPMC11267695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.